Abstract | In contrast to non-mammalian vertebrates, mammals and humans have limited innate capacity for the self-regeneration of tissues and organs owing to differences in genetics, development, immune systems and tissue complexity. Endogenous stem cells are tissue-specific adult stem cells with the capacity to self-renew and differentiate into specific cell types. Therefore, endogenous stem cells are being explored for the regeneration of tissues in situ and in vivo. Stem cells reside in specific niches in the body , and stem cell activation depends on progressive changes in the niche. Niches are specific and instructive microenvironments that can be recreated using biomaterial-based scaffolds. Such scaffolds can be fabricated into a variety of shapes and formulations, and they can be functionalized with biochemical and biophysical cues to guide stem cell fate and migration. In this Review , we discuss important differences in the self-regeneration abilities of non-mammalian vertebrates and mammals, including humans, and investigate adult stem cell populations and their niches involved in tissue repair and regeneration. We highlight natural and synthetic biomaterials and their potential for improving applications of endogenous stem cells and examine the role of interspecies chimaeras in regenerative medicine.
Tissue regeneration using endogenous stem cells holds the potential to greatly impact human health by providing the possibility to repair tissues and organs following injury. For most organisms, the capacity to regenerate tissue morphology and function is essential for long-term survival, although the degree and ability of regeneration vary between different species and depends on the develop mental stage (Box 1). In mammals, the capacity for scar-free healing and regeneration is restricted to the early stages of life and is progressively lost during development 1, 2 owing to the decreasing regenerative capacities of endogenous stem cells (Fig. 1a,b) . For example, in humans, skin scarring commences at approximately 24 weeks of gestation and in mice at 18.5 to 19 days of gestation. The potential for scar-free repair in mouse hearts is gradually lost between the first and seventh day of life. After injury or damage, only a few organs can be fully regenerated in an adult mammal, such as the liver and blood. The liver can repair tissue damage caused by a wide range of physical and toxic injuries 3 , and haematopoietic stem cells (HSCs) are able to restore a fully functional circulation system after transplantation 4 . In most other tissues, injury repair or wound healing usually leads to scar formation or fibrosis, which is a consequence of the loss of regenerative capacity. By contrast, many adult non-mammalian vertebrates retain the capacity to regenerate organs and limbs after injury 2,5-8 (Fig. 1c) . Thus, understanding adult tissue regeneration in non-mammalian vertebrates provides important tools for tissue regenerative strategies in humans.
Regenerative medicine aims at repairing, replacing or regenerating cells, tissues and organs to restore impaired function 9 . New insights in developmental biology, stem cell biology and bioengineering have greatly advanced the field of regenerative medicine, and the regenerative capacity of stem cells has been widely explored to recover tissue functions that have been lost because of tissue damage or disease. Endogenous stem cells are multipotent cells that reside inside specific tissues, where they can self-renew and give rise to different cell types. Compared with exogenous stems cells, the use of endogenous stem cells has the advantage of mitigating risks of rejection and infection. Moreover, endogenous stem cells have a lower risk of tumour formation than induced pluripotent stem cells (iPSCs) [10] [11] [12] .
In principle, endogenous stem cells enable the regeneration or repair of every human tissue and thus hold great promise for the future of translational medicine.
Regeneration ability among species Regeneration in non-mammalian vertebrates
Many non-mammalian vertebrates can repair tissue damage in a scar-free manner at any stage of life (Fig. 1c) . For example, a salamander can not only regenerate the
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2 ), but also the heart, brain, jaw, retina and lens [5] [6] [7] [8] , making amphibians interesting models for the study of regeneration mechanisms. For example, frogs (Xenopus) have a long history as model organisms for the investigation of embryonic development [13] [14] [15] . The regeneration of adult tissues and entire organs in Xenopus and salamanders is a complex, multistep process involving cell types of various origins. For example, the regeneration of a limb can be divided into three distinct stages. First, the wound is healed in a scar-free manner. Second, de-differentiated cells adapt a stem cell-like phenotype following exposure to injury and gain a specific regenerative capacity dependent on the tissue type 16, 17 . The third stage is re-development, which is believed to be a recapitulation of embryonic development in the adult animal. Transcriptomic analysis of these three stages in frog tail regeneration revealed changes in the expression of genes related to inflammation 18 . Deleting a subset of macrophages 17 (macrophage-expressed gene (Mpeg) + cells) that are responsible for maintaining the rate of proliferation during blastema formation (Box 1) in zebrafish further demonstrated the impact of the immune system on scar-free tissue regeneration. The absence of Mpeg + macrophages results in the altered expression of key developmental genes in zebrafish that control patterning, the inflammatory landscape and tail fin growth during the regenerative process. Therefore, blastemal generation through reprogramming of cells in the injury area and a specific immune reaction are essential factors for tissue regeneration. These studies demonstrate that the timing and specific type of immune cell recruitment are essential factors for tissue regeneration, as well as the importance of the immune system in scar-free regeneration in amphibian and fish models 19, 20 .
Regeneration in mammals
In contrast to amphibians, regenerative capacities are limited in mammals (Fig. 2) . Tissue regeneration after injury is accomplished by stem cells that reside in the local environment, are recruited from circulation or undergo transdifferentiation 21 . The regeneration mechanisms vary among different tissues, with little or no selfrenewal activities in the central nervous system and the heart, slow cell turnover in the liver and lung and active renewal in skin and blood. During mammalian tissue regeneration, the innate immune response strongly affects the injury repair process. Immune cells play an important role in the restoration of tissue homeostasis by clearing cellular debris, remodelling the extracellular matrix (ECM) and producing multiple cytokines and growth factors. For example, macrophages contribute to tissue regeneration and wound healing in mice [22] [23] [24] . Impaired macrophage function can lead to aberrant repair, such as abnormal production of inflammatory mediators and growth factors, deficiency of antiinflammatory factors and impaired interactions between macrophages and endothelial cells, epithelial cells and endogenous stem cells. Thus, loss of tolerance associated with the emergence of the adult adaptive immune response may contribute to the loss of the regeneration ability in later stages of development 25 . Precise regulation of inflammation is crucial for the correct formation of new tissue, because of the importance of the inflammatory response in creating a scar-free wound healing environment to ensure initiation of cellular reprogramming and activation of progenitor cells.
The regenerative capacity of most mammalian tissues is restricted to an early developmental stage and is lost shortly after birth, and thus adult tissues have limited regenerative potential, showing scar formation and abnormal tissue re-organization during wound healing (Fig. 2) . However, a certain degree of tissue regenerative capacity is maintained in the adult skeletal muscle, oral mucosa and most of the liver 26, 27 . From differences in the immune system in different species, it is hypothesized that the loss of regenerative capacity is related to the evolution of immune competence (Fig. 2) . However, the relationship between tissue regeneration and the immune system is complex, and the immune response can play both negative and positive roles depending on the tissue, organ and life stage. For example, the potential for scar-free repair in mouse hearts is gradually lost between embryonic day 1 (E1) and E7 (ReF.
1 ) owing to the development of both the innate and the adaptive immune system 28, 29 . In mice, the adaptive immune system develops around birth, while in humans, it develops at week 10 of gestation 30, 31 . Skin scarring commences at ~24 weeks of gestation in humans and at 18.5-19 days in mice [32] [33] [34] , marking the transition point from scar-free healing to scarring in the skin (Fig. 1a,b) .
The ability to heal wounds without scar formation has been demonstrated in all mammalian embryos that have been investigated thus far, including marsupials,
Box 1 | Reparative regeneration

Blastema-mediated epimorphic regeneration
In salamanders, transected limbs can be regenerated through blastema formation. This regenerative process is facilitated by locally recruited, lineage-restricted progenitor cells or reprogrammed pluripotent stem cells that proliferate to form a heterogeneous population of cells, which differentiate into specific cell types to replace the damaged tissue. Thus, newly regenerated cells are derived from either resident progenitor or stem cells, through transdifferentiation of mature tissue or through a combination of both processes 281 .
Proliferation and differentiation of recruited or resident stem cells 7 This is the most commonly used process for tissue repair in mammals. For example, multipotent leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)
+ intestinal stem cells exist at the intestinal crypt base and give rise to the full diversity of cell types in the adult intestinal epithelium throughout life 282 .
De-differentiation and re-differentiation of mature cells This process involves de-differentiation and proliferation of existing mature somatic cells and their subsequent re-differentiation into a specific mature cell type, for example, the almost complete structural and functional regeneration of resected zebrafish hearts or heart regeneration following myocardial infarction-induced injury in adult mice [283] [284] [285] [286] .
Transdifferentiation of mature cells
This mechanism was initially observed for lens regeneration in adult newts, in which pigmented epithelial cells from the iris undergo transdifferentiation into lens epithelial cells 287 . Similarly, mouse mesoderm is transdifferentiated into cardiac myocytes through overexpression of two cardiac transcription factors and a cardiac-specific subunit of BAF chromatin-remodelling complexes (for example, BAF60C; also known as SmARCD3) 288 . mice, rats, rabbits, sheep and pigs 35 . Increasing evidence suggests that after injury, either endogenous stem cells or resident de-differentiated cells repair tissues in conjunction, and crosstalk occurs with the immune system, the extracellular matrix, soluble growth factors and cell signals. However, the immune response, ECM deposition and remodelling, and growth factor secretion differ between injured embryonic and adult tissues 36 . In the embryo, the immune response is characterized by a minimal inflammatory response and an increase in the expression of anti-inflammatory cytokines, such as interleukin-10 (IL-10) [37] [38] [39] [40] . The ECM of embryonic wounds has a relatively high type III to type I collagen ratio, whereas in adult wounds, the ECM contains less type III collagen 41 . Specific ECM remodelling processes that do not occur in adult wounds also contribute to scar-free wound healing in the embryo. Moreover, higher expression levels of high-molecular-weight hyaluronic acid (HA) are characteristic of fetal wound healing 42 . Finally, the expression of transforming growth factor β3 (TGFβ3), synthesized by keratinocytes and fibroblasts, is higher in non-scarring fetal wounds 43 . These differences between embryonic and adult wound healing observed in mice have shed light on the mechanisms of mammalian tissue regeneration during development. However, how the inflammatory responses differ between mice and humans is not yet well understood 44 . Interactions among immune cells, endogenous stem cells and mesenchymal cells decide whether regeneration-specific processes are initiated, and they have an impact on scar tissue formation. For example, interactions between macrophages and T cells play a key role in muscle regeneration in zebrafish 19 and mice 20, 45 . These specific cell-cell interactions depend on the type of injury, tissue location and developmental stage. Reprogramming of cells into stem cells at the site of injury, recruitment of endogenous stem cells from the blood and direct differentiation of residual endogenous stem cells are key to tissue and organ regeneration in amphibians and fish.
Despite sharing many biological characteristics with humans, vertebrates such as the salamander and zebrafish have developed unique molecular circuits and physiological traits to thrive in their environments. However, whether the ability of adult tissue regeneration is an ancestral trait that was lost during mammalian evolution or whether it developed independently through different evolutionary paths remains elusive.
Stem cells in tissue regeneration
Stem cells are characterized by the ability to self-renew, proliferate and differentiate into mature functional cells in a cell-lineage-specific fashion. The two main types of stem cells are pluripotent stem cells (embryonic stem cells (ESCs) and iPSCs), which can differentiate into cell types of all three embryonic germ layers, and multipotent and unipotent stem cells (also known as adult stem cells), which have limited proliferation and differentiation potential 46, 47 . Endogenous stem cells are tissue-specific adult stem cells with the capacity to self-renew and differentiate into specific cell types. Endogenous stem cells, for example, HSCs, enable cell turnover to maintain tissue function and normally remain quiescent in the tissue and are activated only in response to tissue injury or loss of homeostasis to repair the tissue and restore tissue function. However, severe tissue damage cannot be repaired by means of such natural repair processes, thus leading to scar formation and eventually loss of tissue function.
Tissue injury activates resident endogenous stem cells to leave the quiescent state to restore tissue function. In the liver, adult endogenous stem cells can also be recruited from adjacent epithelial cells through signals from the ECM 48 . Moreover, the self-regeneration of injured adult tissue requires the migration of a sufficiently high number of endogenous stem cells and progenitor cells from multiple tissues to the injury site through the ECM and subsequent differentiation into mature cell types. Thus, stem cell homing to the damaged area also plays a key role in tissue regeneration and needs to be considered when designing stem-cell-based The capacity of tissue and organ regeneration varies in different animal species. a | In mice, the capacity for scar-free repair decreases between embryonic day 15 (E15) and E16. The capacity for heart and spinal cord regeneration is lost in early postnatal life between postnatal day 1 (P1) and P7. Limb regeneration is lost early in development (before E15). Whole digits can be regenerated until E16, and digit tip regeneration is maintained throughout the development stages 289 . b | In humans, the regenerative potential is limited to early developmental stages, similar to mice. c | In salamanders, the ability for scar-free repair and the regeneration of limbs, heart, brain, spinal cord, tail and retina are maintained throughout their life.
therapies for tissue regeneration. Understanding the navigational cues and mechanisms that efficiently direct stem cells to a site of injury is an active area of research 48 . For example, ex vivo fucosylation of CD44 on the surface of mesenchymal stem cells (MSCs) promotes adhesive interactions between the stem cells and the bone marrow vasculature, enabling stem cell homing to endosteal surfaces 49 . The use of endogenous stem cells in regenerative medicine has several advantages over the use of ESCs and iPSCs. First, ethical issues related to ESCs can be avoided by using endogenous stem cells. Second, employing autologous endogenous stem cells reduces the risk of immune rejection and avoids complications associated with cell transplantation. Third, endogenous stem cells can be derived from a variety of sources, including the amniotic fluid 50 , umbilical cord tissue (Wharton's jelly) 51 , fat tissue 52 , central nervous system 53 , bone marrow 54 , retina 55 and skin 56 . Adult endogenous stem cells can also be obtained from mature cell types through overexpression of specific genes to de-differentiate them into stem cells. Alternatively, the cell fate of mature cells can be modulated to contribute to tissue repair processes. For example, cardiomyocytes can be forced to enter mitosis through overexpression of specific cell cycle genes for heart regeneration 57 . Similarly, gene networks can be activated in damaged tissue during development to induce global shifts in the transcriptome and epigenome driving cell fate decisions. Moreover, direct re-programming of cells can be applied to harness resident support cells and convert them into desired cell types in situ 58 . Tissues and organs have unique heterogeneous stem cell populations, displaying different transcriptional profiles and self-renewal abilities.
Mesenchymal stem cells
MSCs are capable of self-renewal and differentiation into multiple cell types, such as osteoblasts (bone), chondrocytes (cartilage), myocytes (muscle) and adipocytes (fat). They are multipotent and can be easily derived from a variety of tissues, including fat, skin and bone marrow. Currently, MSCs are mostly extracted from bone marrow and gingiva. MSCs can differentiate into many types of connective tissue cells responsible for the remodelling of cartilage, bone, fat and vascular tissue. Human adult MSCs are non-haematopoietic, adherent, fibroblast-like cells with the capacity for multilineage differentiation 59, 60 (Fig. 3) .
Bone marrow-derived mesenchymal stem cells. Bone marrow-derived MSCs were first described as a hetero geneous population of stromal cells. In bone marrow, they support the tissue structure during haematopoiesis [61] [62] [63] . The term bone marrow stromal cells (BMSCs) was first used for isolated bone marrow cells that have the potential to form tissues supporting haematopoiesis 64 . A subpopulation of these cells is multipotent and can generate the 'mesenchyme' , which develops from the embryonic mesoderm layer. Bone marrow-derived stem cells were first identified by Ernest A. McCulloch and James E. Till 65 , and they were isolated and described by Friedenstein and Owen in the 1960s [66] [67] [68] . MSCs are present in all postnatal tissues 54, 69, 70 and can differentiate into multiple mesenchymal tissues in vitro, including bone 71 , ligament 72 , adipose 73 , cartilage 74, 75 and muscle 76 . Following transplantation, MSCs can form small deposits of bone, cartilage or fat [77] [78] [79] [80] in vivo. MSCs can also be isolated from other mesenchymal tissues, including the synovia 81 , tendons 82 , skeletal muscles 83 and adipose tissue 52, 84, 85 , for example, from the fat pad of the knee joint 86 . MSCs have also been found in peripheral blood 87 . BMSCs have important properties for therapeutic use, for example, the ability to travel to specific distant sites in the body, to interact with the immune system, to produce bioactive molecules and to repair damaged tissues. Therefore, BMSCs can be used for immunomodulation, in tissue engineering and for the repair of diseased mesenchymal tissues, for example, to treat musculoskeletal conditions and cardiovascular, liver, kidney and neurological diseases. BMSCs support a regenerative microenvironment by secreting different bioactive molecules in a paracrine or autocrine manner, supporting the intrinsic regenerative capacity of tissues through modulation of the immune and inflammatory response and through growth factor secretion, providing a suitable environment for tissue regeneration 88, 89 (Fig. 3 ).
Adipose tissue-derived mesenchymal stem cells. Human adipose tissue is a rich source of multipotent stem cells. Adipose tissue-derived stem cells (ADSCs) can differentiate in vitro 90 and in vivo 91 into various cell types, including cells of chondrogenic 85, 92 , adipogenic 52, 93 , hepatic 94 and neurogenic lineages 95 . For example, ADSCs can be cultured in myogenic conditions in vitro, triggering the expression of muscle-related genes to produce beating cardiomyocytes 96 . Haematopoietic cells can be derived from a mouse adipose-tissue-derived stromal vascular fraction 97 . The phenotype and genotype of ADSCs are similar to those of BMSCs at a transcriptional level 98 . However, their differentiation potentials are different; for example, chondrogenic differentiation is better in BMSCs than in ADSCs 99 under similar culture conditions in vitro 100 . Thus, BMSCs are preferably used in the clinic to control graft-host reactions in haematopoietic transplantation 101 . However, ADSCs also possess immunomodulatory functions 102 and can be applied for tissue regeneration. For example, a young patient with several calvarial defects following head injury was treated with autologous ADSCs 103 and showed increased bone formation and near-complete healing.
Skin-derived mesenchymal stem cells. Skin develops from the embryonic ectoderm germ layer and is the largest organ of the human body. Multipotent cells can be derived from the dermis of juvenile and adult rodents 56 . These cells can proliferate and differentiate into both neural and mesodermal cell types, including neurons, glia, smooth muscle cells and adipocytes. Human adult skin tissues also contain cell populations with pluripotent characteristics that can be differentiated into multiple cell lineages [104] [105] [106] . Owing to their abundance, skin stem cells can be easily expanded for the treatment of previously incurable human skin disorders and diseases, including alopecia, scarring, skin cancer and serious burns 104, 107 . Dermal-derived stem cells (DSCs) also have chemokine-mediated homing potential similar to that of BMSCs and ADSCs [105] [106] [107] . Stem cells residing in the adipose tissue and dermis of human skin are thought to be involved in the healing of deep skin wounds, because adipose tissue is exposed in the wound bed and dermal tissue at the wound bed margins 106 . Thus, establishing optimal chemokine and cytokine gradients within the wound bed is important for stem cell homing and can be explored for the treatment of skin wounds, for example, for deep burns to reduce scarring or for chronic wound ulcers to close the wound 106 . BMSC homing into the epidermis of mouse skin, followed by transdifferentiation into keratinocytes, is known to be regulated by specific chemokine-receptor and tissue regeneration; pro-angiogenic growth factors include vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF1), monocyte chemoattractant protein 1 (MCP1), basic fibroblast growth factor (bFGF) and interleukin-6 (IL-6); growth factors for stem cell growth and differentiation include stem cell factor (SCF), leukaemia inhibitory factor (LIF), macrophage colony-stimulating factor (MCSF), stromal derived factor 1 (SDF1), angiopoietin-1 and activin A ; fibrosis is inhibited by hepatocyte growth factor (HGF), bFGF and adrenomedullin (ADM); and apoptosis is inhibited by VEGF, HGF, IGF1, transforming growth factor β (TGFβ), bFGF, granulocyte-macrophage colony-stimulating factor (GMCSF), activin A and thrombospondin-1. Local homing leads to the transdifferentiation of MSCs into tissue-specific cell types. MSC signalling also triggers the differentiation and proliferation of regulatory T cells (T reg ) through TGFβ expression, inhibition of natural killer (NK) cells through secretion of indoleamine 2,3-dioxygenase (IDO), prostaglandin E2 (PGE2) and TGFβ, and inhibition of dendritic cell (iDC) maturation (mDC) by secretion of PGE2. Adapted with permission from ReF. interactions, particularly between chemokine (C-C motif) ligand 27 (CCL27) and the C-C chemo kine receptor type 10 (CCR10) 105, 108 . However, the intrinsic and extrinsic signals dictating the fate of skin epidermal progenitors and the corresponding migration mechanisms remain elusive.
Lens regeneration
The ocular lens is derived from the surface ectoderm, and regeneration has been reported in non-mammalian vertebrates 109 , initiated from different cell types in newts and Xenopus laevis. In mammals, for example, rabbits, the lens can be spontaneously regenerated from residual epithelial cells following removal of the original lens 110, 111 , which was first described by Cocteau and Leroy d'Etoille in 1827 (ReF.
112 ). Biomaterial-based approaches have also been explored for lens regeneration. For example, sealing of the capsulotomy opening after removal of the lens contents restores the integrity of the anterior capsule, and subsequent refilling of the capsule with a biomaterial helps to prevent adhesions and wrinkling, improving the shape and size of the regenerated lens 113 . Moreover, several drugs have been explored to promote lens regeneration. Lentropin, which is an insulin-like growth factor (IGF) 114 that can be isolated from the chicken vitreous humour, stimulates lens stem (LES) cell differentiation. Similarly, fibroblast growth factor (FGF) also promotes LES cell differentiation.
In humans, disorganized regrowth of doughnut-like lens tissues has been observed after congenital cataract removal in infants. Paired box protein Pax-6-positive and polycomb complex protein Bmi-1-positive LES cells are present throughout human life and are crucial for lens regeneration 115 . Cataract can be surgically removed to preserve endogenous LES cells and their microenvironment to enable functional lens regeneration. However, the mechanisms for lens regeneration in humans and the regeneration of a complete functional mammalian lens remain elusive.
Liver regeneration
The liver has a high capacity for regeneration and is composed of two main epithelial cell types, hepatocytes and cholangiocytes. Hepatocytes play a central role in metabolic activities, and cholangiocytes serve as conduits for bile transport to the intestine. In response to injury or after considerable loss of liver parenchyma, endogenous hepatocytes and cholangiocytes are activated from a quiescent state to repair the damage 116 . In the healthy liver, these cells have a very low turnover rate, but in response to an acute injury, they proliferate and differentiate through many divisions. The liver also contains facultative stem cells, which reside near the portal region of the hepatic lobule in the Canal of Herring. Once activated, these stem cells proliferate and differentiate first into bile duct cells and hepato cytes and then into functional mature hepatocytes. In chronic liver disease, hepatocyte and cholangiocyte proliferation and differentiation are impaired, and a backup mechanism of regeneration is initiated, in which liver progenitor cells differentiate into hepatocytes or cholangiocytes. These endogenous liver progenitor cells are being explored for therapeutic applications in liver disease 117 .
Cardiac regeneration
Heart failure is associated with high morbidity and mortality, and the total costs for the treatment of heart failure are projected to reach $70 billion by the year 2030 in the US 118 . The pathophysiological basis of heart failure is the inability of the adult heart to regenerate lost or damaged myocardium 119 . Myocyte turnover is limited in the adult heart and is insufficient to restore cardiac tissue integrity and contractility. However, complete regeneration can be achieved in E1 mice embryos 1 through proliferation of residual cardiomyocytes after removal of up to 15% of the apex of the left ventricle. Importantly, these newly formed cardiomyocytes are derived from residual cardiomyocytes and not from progenitor or stem cells 120 . The cardiomyocyte turnover rate is similar in humans 120 . Cardiomyocyte renewal is regulated by aerobic-respiration-mediated oxidative DNA damage 121 . After myocardial infarction, gradual exposure to systemic hypoxaemia causes reactivation of cardiomyocyte mitosis, initiating a regenerative response to limit myocardial fibrosis, to restore left ventricular systolic function and to decrease reactive oxygen species (ROS) production and oxidative DNA damage 121 . The expression of the oxygen-dependent degradation (ODD) domain of hypoxia-inducible factor 1-α (HIF1α) is induced under a cardiomyocyte-specific myosin heavy chain (MHC) promoter to drive new cardio myocyte formation in the adult heart. Interestingly, cardiomyocytes subjected to hypoxic conditions become similar to fetal or neonatal cardiomyocytes, but these cells are smaller in size and show mononucleation and DNA damage caused by oxidative stress, which can lead to a decrease in cardiomyocyte turnover in postnatal mammalian hearts.
There are two theories to explain cardiomyocyte regeneration in adult mammals: resident progenitor and stems cells give rise to new cardiomyocytes, or mature cardiomyocytes re-enter mitosis to generate new cardiomyocytes. Resident cardiac progenitor cells (CPCs) are adult stem cells, and stem cell growth factor receptor (c-Kit) + CPCs have been shown to produce new cardiomyocytes and support myocardium regeneration 122, 123 . However, only a minimal number of cardiomyocytes can be generated by c-Kit + CPCs in vivo, and resident cardiac c-Kit + CPCs predominantly transdifferentiate into endothelial cells 124 . The generation of a sufficiently high number of functional cells for cardiac transplantation is challenging. Cardiovascular progenitor cells can be obtained through de-differentiation of mature cells. These progenitor cells can then be expanded and differentiated into cardiomyocytes, smooth muscle cells and endothelial cells in vitro and transplanted into mouse hearts following myocardial infarction for cardiac regeneration; however, their proliferation capacity is limited 125 .
Endogenous stem cell niches
The stem cell niche The adult stem cell microenvironment, or stem cell niche, anchors stem cells within a tissue and allows long-term self-renewal for both undifferentiated stem cells and specialized, differentiated cells 126 . Niches are important to keep stem cells in an undifferentiated, quiescent state and play a key role in the activation of stem cells; for example, pure populations of HSCs under go differentiation when not residing in their niche 127 . Several types of stem cell niches have been identified, including HSC and MSC niches in bone marrow (Fig. 4a) , germline stem cell (GSC) niches in ovaries and testes, epithelial stem cell niches in epithelia (hair follicles, skin, intestinal crypts and corneas), neural stem cell niches in the brain, satellite cell niches in skeletal muscle (Fig. 4b) , dental pulp stem cell niches in teeth and cancer stem cell niches in tumours. Stem cell niches of different tissues and species have many structural similarities, but they differ in their functional characteristics. Stem cell niches are highly dynamic and composed of multiple cell types. The niche reciprocally interacts with stem cells through complex biochemical and biophysical events 128 . A stem cell niche typically contains solid components, including cells and ECM, and soluble factors, such as growth factors. MSC and HSC niches contain a large number of different cell types and thus perform regulatory functions at a systemic level 129 . Some other niches are composed of fewer cell types and play only a local regulatory role, such as those in the intestine and dermis. In response to a tissue-specific stimulus, stem cells migrate to the respective site in the tissue, differentiate, proliferate and ultimately re-establish tissue homeostasis. Stem cell niches are mostly located deep within a tissue to maintain concentration gradients of oxygen, ions, growth factors, cytokines and/or chemokines and thus are often difficult to identify and investigate. In addition, most stem cell niches are embedded within an ECM produced by stem cells or their daughter cells. Therefore, the ECM of the niche is often very similar to that of the surrounding tissue and difficult to distinguish 127 .
Cell-ECM interactions
The ECM acts not only as a physical scaffold for cells and signalling molecules but also as a major regulator and determinant of stem cell fate in the niche 130 . The matrix is composed of a variety of secreted cellular proteins and dynamically interacts with resident cells. ECM alterations, such as structure degeneration, often accompany disease progression, for example, in cardiomyopathies 131 . Therefore, understanding ECM composition and signalling is important for establishing design cues to replicate its structure and function. Tools such as immunohistochemistry provide valuable information regarding protein composition, and electron microscopy allows for study of the ECM structure. Decellularization can be further applied to strip tissues of cells to prepare an intact ECM. The ECM of relatively simple tissues, such as the skin, is easy to study and replicate, but the matrix of vascularized structures is challenging to analyse owing to the complexity and dynamics of these tissues.
The structural characteristics of ECMs of certain tissues or organs are dictated by function. For example, in the heart, which is one of the first organs gaining function during development, a myriad of specialized cell types must be assembled within the ECM and cooperate to be able to pump blood 132, 133 .
In bone tissue, ECM molecules organize in a shortrange order to provide structural integrity, to withstand and transmit large forces and to protect vital organs. Bone tissue is continually remodelled throughout life by various cell types, including osteoblasts, osteocytes and osteoclasts 134 . Osteoblasts are responsible for bone generation through secretion of type I collagen and minerals, and osteoclasts participate in the resorption of deposits.
Cell-ECM interactions are mediated by different cellular receptors, for example, integrins and cadherins, which are adhesion molecules that are crucial for the migration and localization of cells 135 . Additionally, they play an important role in cell survival and differentiation 136 . Integrins are dimers consisting of combinations of α-and β-subunits that are capable of binding to ECM components 137 . Thus far, 24 different α-subunits and 9 different β-subunits have been reported in mammals 137 . Common integrin binding partners are fibronectin, vitronectin, collagen and laminin. Differential integrin expression dictates the type of niche to which cells migrate, and integrins β1, α5 and αV are commonly expressed in human adult stem cells. Some integrins can also bind to intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1), which are also part of stem cell niches 138 . Stem cell differentiation is affected by the surrounding ECM, cell-cell contacts and growth factors 127, 139 . The ECM plays an important role in maintaining stem cell identity and regulating stem cell activation, for example, by providing structural integrity; the ECM also physically separates the stem cell population from resident cells and the interstitial matrix. Moreover, the composition, porosity and stiffness of the ECM impact stem cell activity, and the physical and mechanical properties of the ECM are important for cell-ECM interactions through focal adhesions [139] [140] [141] . Therefore, different differentiation pathways can be triggered depending on the composition and properties of the ECM. For example, the stiffness of the ECM plays a key role in the differentiation of MSCs; variations in ECM stiffness affect proliferation, migration and differentiation of MSCs. MSCs residing in bone marrow promote osteogenesis 142 but contribute to fibrotic tissue formation within perivascular niches by differentiating into other lineages. In addition to physical ECM characteristics, growth factors and glycoproteins localized within the ECM serve as important regulators for balancing the activation and quiescence of stem cells.
Biomaterials for tissue regeneration
Biomaterials can be employed to rationally engineer instructive microenvironments to stimulate and recruit resident stem cells or progenitor cells in vivo, to provide cues for native healing cascades and to promote cell differentiation and proliferation for tissue repair. The therapeutic outcome of biomaterial-enabled endogenous regeneration depends on effective cell homing and control of cell fate. Engineered scaffolds have been explored as artificial matrices for cell recruitment and proliferation, supplying instructive cues to direct cell phenotype for tissue regeneration. The design of functional scaffolds involves the fabrication of natural and synthetic biomaterials, the construction of 3D architectures and the implementation of modulatory capabilities (Fig. 5 ).
Synthetic and natural biomaterials Synthetic biomaterials. Many synthetic polymers are biocompatible and biodegradable, allowing them to match the rate of tissue regeneration. Synthetic polymers can further be used to encapsulate signalling molecules and control their release. The physicochemical and mechanical properties of many synthetic polymers can be tuned to match those of damaged tissues, and they can be processed into various formulations for administration (TaBle 1) . Poly(lactic-co-glycolic acid) (PLGA) has been widely explored to enable and direct homing of autologous stem cells, for example, for c-Kit + CPCs in combination with FGF1 and neuregulin 1 (NRG1) 143 , for human MSCs to induce osteogenic differentiation using either recombinant human growth-differentiation factor 5 (rhGDF5) 144 or autologous serum 145 , for HSCs to increase fibrotic and angiogenic processes using stromal cell-derived factor 1α (SDF1α) 146 and synovium, and for bone marrow and adipose stem cells to induce chondrogenesis using human TGFβ3 (ReF.
147
). Poly-ε-caprolactone (PCL) has been used in combination with bone morphogenetic protein 2 (BMP2) 148 , TGFβ3 (ReF.
149
), SDF1 (ReF.
150
) and connective tissue growth factor (CTGF) 151 to direct homing of human MSCs for osteogenesis.
Knowledge gained from the use of PLGA and PCL has motivated the rational design of new materials for endogenous regeneration. For example, sebacic acid and glycerol can be polymerized to form poly(glycerol sebacate) (PGS) 152 . PGS has the same degradation characteristics as PCL and PLGA but shows superior deformability owing to the 3D network structure made of random coils, mimicking the elasticity of native ECM 153 . PGS can be applied for cardiogenic differentiation of MSCs because of its long-term elasticity response to the dynamics of the heart muscle. The biodegradation of PGS can further be tuned for specific applications, and tissues and can be used to deliver and retain beating cells in the heart [154] [155] [156] . A facile thiol-ene click reaction can also be used to synthesize polymers with elastomeric mechanical behaviour comparable to that of PGS but with prolonged degradation times in vivo 157 to maintain the structural integrity and elastomeric mechanical behaviour of the scaffold long term. Materials can also be designed to minimize environmental stimulation and limit spontaneous cell differentiation to maintain stem cell multipotency. For example, superhydrophilic zwitterionic materials have ultra-low fouling properties 158 , inhibiting nonspecific cell-polymer interactions. Such materials can be used to maintain the phenotype and multipotency of human MSCs subjected to various external stimulations 159 . Thus, manipulation of non specific cellmatrix interactions can be used to reversibly trigger or suspend stem cell differentiation 160 . Natural biomaterials. Natural materials, including proteins, polysaccharides and polyhydroxyalkanoates, can also be used as scaffolding materials for endogenous regeneration 161 ( TaBle 1) . For example, BMP7 can be loaded into a collagen type I scaffold, which can then be applied in patients with fibular defects 162, 163 . In a clini cal study, the treatment group showed significant formation of new bone after six weeks, whereas the b | In the skeletal muscle, the niche for satellite cells is formed by the myofibre plasma membrane and basal lamina. The basal lamina is a network of ECM components, including laminin, collagen IV, collagen VI, fibronectin and proteoglycans. Satellite cells are anchored to the niche through interactions of specific receptors, such as α7β1 integrin and syndecan-4, with the basal lamina, and through cell-cell contacts (M-cadherin) with the myofibre. A complex set of diffusible factors (for example, Wnt, insulin-like growth factor (IGF) and fibroblast growth factor (FGF)) are exchanged between the satellite cells and the myofibre to maintain quiescence or promote activation 292 . bFGF, basic fibroblast growth factor ; CXCL , CXC-chemokine ligand; EGF, epidermal growth factor ; HGF, hepatocyte growth factor ; SCF, stem cell factor ; SDF1, stromal derived factor 1; TGFβ, transforming growth factor β. Panel b is adapted from ReF.
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control group treated with a collagen gel without BMP7 did not show significant new bone formation 162 . Similarly, human BMP2 loaded into an absorbable collagen sponge (InFUS Bone Graft, Medtronic Sofamor Danek) promotes osteoinduction and improves tissuebone graft fusion 163 . Collagen loaded with SDF1 or basic FGF (bFGF) can also be used to recruit MSCs for bone regeneration 164 . Subcutaneously implanted hepatocyte growth factor (HGF)-loaded collagen gels trigger the migration of endogenous MSCs to accelerate healing of incisions in mouse skin 165 . Similarly, alginate and gelatine gels can be applied to recruit MSCs for osteogenesis by releasing signalling molecules such as FGF2 and BMP2. Gelatine can further activate local satellite cells by a combinatorial delivery of vascular endothelial growth factor (VEGF), promoting angiogenesis and activating IGF1 for muscle regeneration.
Silk is a naturally occurring polymer that is lightweight, strong and elastic 166, 167 . Various techniques have been developed to process raw silk into versatile biomaterials 168 . Silk can also be genetically manipulated to improve its properties. For example, recombinant approaches can be applied to decrease the degree of crystallinity in silk fibroins to improve elasticity and water solubility 169 . Porous silk protein scaffolds can be loaded with VEGF and BMP2 to trigger homing of endogenous cells, such as BMSCs, and to locally initiate differentiation into endothelial cells and osteogenic cells for bone regeneration 170 . Silk can also be combined with collagen, resulting in a scaffold with an optimal mechanical strength and patterned structure. For example, a ligament scaffold can be constructed by combining knitted silk fibres with a collagen matrix. The silk fibres improve the mechanical strength of the material, and their knitted structure mimics connective tissues in ligaments and tendons, supporting the collagen matrix in modulating ligament regeneration 171 . Native ECM can also serve as a natural scaffolding material 172 . Decellularization protocols that maintain the structure and architecture of ECMs have been tailored to accommodate the characteristics of specific tissues 173 and to mimic stem cell niches 174 . The decellularization process also preserves biochemical cues of the ECM 175 , making it an interesting material for endogenous regeneration. For example, bone ECM can be used as a scaffold to recruit endogenous progenitors using various signalling molecules or angiogenic factors, such as VEGF, pro-inflammatory cytokines, such as tumour necrosis factor (TNF)-α and interleukin-1 (IL-1), and BMPs to promote bone regeneration [176] [177] [178] . Treated dentin matrix (TDM) can serve as a natural scaffold for endogenous tooth root regeneration 179 . Decellularized dental matrix can be modified with platelet-rich fibrin (PRF) made from autologous venous blood to provide a homing signal for the recruitment of BMSCs and periodontal ligament stem cells (PDLSCs) to regenerate cementum and periodontal ligament-like tissues with orientated fibres and eventually restore the soft-hard tissue interface 180 . A TDM scaffold can be designed to release bFGF and VEGF to regenerate connective tissues in the native dentinal wall in root canals 181 . Decellularized pulmonary valve constructs can be conjugated with CD133 antibodies to promote in situ seeding of endothelial progenitor cells and to improve restoration of the structure and function of heart valves 182 . Natural-synthetic hybrids. Natural materials are limited by weak mechanical properties, low chemical stability, variations in composition and poor resistance to enzymatic degradation 183 . To overcome these limitations, the materials can be chemically modified by introducing resistant surface groups or crosslinking linear chains into the matrix to improve the mechanical properties and the stability 184 . By contrast, synthetic materials often poorly degrade in the body and thus elicit a chronic foreign body reaction. To harness the advantages of both synthetic and natural biomaterials, 'hybrid biopolymers' can be designed using natural and synthetic components to control stem cell fate in situ 185, 186 . Natural materials can be absorbed onto the surface of synthetic scaffolds through non-covalent forces, such as charge and hydrophobic interactions. For example, chitosan 187, 188 , cellulose 189 , HA 190, 191 and collagen 192, 193 have been explored as coating materials to minimize tissue adhesion, contraction, fibrotic capsule formation and inflammation. The adsorbed natural materials can further be crosslinked to reinforce the coating. For example, a gelatine hydrogel can be used both as a coating material for a poly(tetrafluoroethylene) mesh (MotifMesh) and as a drug depot to encapsulate and deliver bFGF 194 . This hybrid material improves angiogenesis at the implantation site over the synthetic mesh alone.
Alternatively, natural and synthetic materials can be mixed into homogeneous materials to construct a hybrid scaffold. For example, PLGA and collagen can be co-dissolved into highly volatile fluoroalcohols, such as 1,1,1,3,3,3-hexafluoro-2-propanol (HFP), and electrospun into fibrillar meshes 195 . Insulin release from the scaffold can potentiate BMSC differentiation into adipocytes and promote skin wound healing. Covalent conjugation can also be applied to engineer hybrid polymers with improved functionalities. For example, click chemistry enables specific conjugation of polyethylene glycol (PEG) onto silk fibroin films, enabling tuneable hydrophobicity to modulate stem cell interactions 196 . Poly(N-isopropylacrylamide) (PNIPAAm) has a low critical solution temperature of 32 °C and can be grafted onto water-soluble chitosan and gelatine 197, 198 . This hybrid material remains liquid at ambient temperature for injection but solidifies after administration. The material can also be loaded with TGFβ3 to induce chondrogenic differentiation of human MSCs in vivo 198 .
3D architectures
Implanted materials must mimic certain properties of the tissue-specific ECM at the site of regeneration to be applicable for endogenous regeneration. The implanted scaffolds must allow efficient nutrient and metabolite transport and provide adequate mechanical stability, which is important for tissue regeneration. Hydrogels crosslinked with soluble precursors provide a good platform 199 for tissue regeneration owing to their large surface-to-volume ratio and high fractional porosity. Thus, hydrogels can provide a microenvironment that mimics the architecture of a biological milieu to direct the 3D organization of cells and de novo tissue synthesis, while enabling complete sealing of the lesion site. Hydrogels can be made of synthetic or natural materials.
For example, a poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) hydrogel can be implanted at an injury site of the spinal cord to recruit nestin-expressing progenitors for endogenous spinal cord repair in the absence of trophic factors 200 , for example, to support progenitor self-renewal and to restore locomotion in cats that underwent spinal transection. Crosslinking of HA and methylcellulose also results in the rapid formation of a hydrogel at physiological temperature. This hydrogel can be loaded with erythropoietin and injected into the brain to recruit endogenous neural stem and progenitor cells for the regeneration and replacement of cells and tissues after a stroke 201 .
To improve hydrogel synthesis, various 'cell-friendly' polymerization methods have been developed, with a focus on minimizing cross reactions during gelation 202 . Conjugation with environment-responsive linkers can be applied to engineer smart hydrogels that respond to the dynamic organization and morphology of stem cells. For example, a 'sliding hydrogel' maintains structural stability but features movable crosslinks to enable molecular mobility to better support stem cell development 203 .
Crosslinked hydrogels typically possess a nanoporous network structure; however, hydrophilic networks with larger interconnected pores better enable efficient cell infiltration and deployment, provide a larger surface area for cell attachment and interaction, and facilitate faster diffusion of oxygen, nutrients and signalling molecules. Therefore, nanofibres have been explored as macro po rous scaffolds. For example, self-assembled peptide nanofibres combined with VEGF can create an intramyo cardial microenvironment enabling long-term VEGF release to improve post-infarct neovascularization and to recruit cardiomyocyte-like cells for cardiomyocyte regeneration 204 . Nanofibres also mimic the fibrillar structure of the ECM for tissue-specific regeneration 205 . For example, radially aligned PCL nanofibres mimicking the dura mater induce faster cellular migration and population of dural fibroblasts than non-woven fibre mats with random nanofibre orientation 206 . Similarly, the , poly-ε-caprolactone (PCL) [148] [149] [150] [151] , poly(lactic-co-glycolic acid) (PLGA) [143] [144] [145] [146] [147] , poly(glycerol-sebacate) (PGS) [154] [155] [156] • Ceramics: alumina 300 , zirconia 249 , hydroxyapatite 301 , tricalcium phosphate 192 , tetracalcium phosphate 302 , bioactive glass 303, 304 , calcium phosphate 305 • Protein-based: silk 306, 307 , collagen 308 , fibrin 309 , gelatin 310 • Polysaccharide-based: hyaluronan 311 , alginate 312 , agarose 313, 314 , chitosan 312 • Polyester-based: polyhydroxyalkanoates (PHAs) 315 • Native extracellular matrix 316, 317 
Typical formulations
•
Major degradation mechanism
Hydrolysis Enzymatic degradation
Strengths
• Broad tunability • High reproducibility
• Good cytocompatibility and biocompatibility • Built-in bioactivity
Weaknesses
• Weak biological activity in promoting tissue regeneration • Unpredictable cytocompatibility and biocompatibility
• Low mechanical strength • Immunogenicity (xenologous sources)
• Batch-to-batch variability structural organization of collagen fibres at the tendonto-bone interface can be recreated in an 'aligned-torandom' nanofibre scaffold, inducing cell differentiation into both aligned and random morphologies for the repair of injuries at the tendon-to-bone interface. Various other fabrication techniques have been explored for the design of macroporous scaffolds, including solvent casting, particle leaching, gas foaming, phase separation, cryogelation and crosslinking, offering promising opportunities for endogenous regeneration 207, 208 . 3D printing enables the construction of scaffolds that mimic native ECM structures. 3D printing techniques allow the fabrication of a range of biocompatible, precise and anatomically correct biomaterials using cell-friendly crosslinking methods for endogenous regeneration 209, 210 . For example, 3D printing has been used to fabricate a scaffold featuring three continuous zones for endogenous periodontium regeneration: 100 μm channels for the cementum-dentin interface, 600 μm channels for the periodontal ligament and 300 μm channels for the alveolar bone. The heterogeneous structure in conjunction with different growth factors enables differentiation of a single progenitor cell population into three different tissues 211 . For endogenous knee meniscus regeneration, 3D printing techniques can be applied to replicate both the overall shape of the human meniscus and the microstructures of meniscal collagen, with interlaid strands and interconnecting microchannels aligned along the circumferential direction. These fine structures serve as conduits for cellular ingrowth and nutrient diffusion and are essential for endogenous meniscus regeneration 212 . Decellularized ECM materials derived from adipose, cartilage and heart tissues have also been used as biomaterials for 3D printing 213 . Printed ECM scaffolds enable high cell viability, differential lineage commitment and de novo ECM formation. Indirect methods, such as the integration of sacrificial moulds with 3D printing, facilitates the fabrication of scaffolds with fine details 214 . Therefore, 3D printing has great potential for the engineering of complex tissue scaffolds for endogenous regeneration.
Three-dimensional scaffolds can also be made in situ using injectable materials 215 (Fig. 6 ). Injectable scaffolds do not require prior knowledge of the size and shape of the defect, because they can readily fill the cavity of an irregular shape. An injectable formulation allows the homogeneous distribution of cells and molecules within the scaffold, therefore avoiding non-uniform cell distribution and tissue formation, as is often the case for implantable scaffolds. Injection is also minimally invasive. Scaffolds can be administered by injecting a precursor solution that crosslinks through compatible reactions in situ. Controlled gelation can be achieved through crosslinking reactions that are responsive to local environmental cues, such as ion concentration, hydrophobicity, heat, light or enzymatic activity 216 . For example, oligopeptides selfassemble into nanofibrous gels triggered by the salt concentration at physiological pH in vivo, resulting in peptide-nanofibre scaffolds that are slowly degraded, low in immunogenicity and therapeutically potent for endogenous stem cell homing. Such nanofibre scaffolds can be used to create a vascular niche for the homing of cardiac troponin I (TNNI3) + small cells for cardiomyocyte regeneration 204 and of MSCs for neovascularization 217 . Alternatively, injectable scaffolds can be designed by using shear-thinning materials, such as hydrogels, polymer blends and colloidal systems 218, 219 , which can be exploited for in situ cell homing and infiltration. These systems flow under the moderate pressure experienced during injection, self-heal after injection and form network structures under physiological conditions. These materials provide continuous, yet locally reconstructible structures for endogenous regeneration. For example, shape-memory materials can be compressed for injection under moderate pressure; following injection, they regain their original shape and size in situ 220 .
Functionalization of biomaterials
Molecule encapsulation and delivery. Most stimulating and homing agents used to trigger stem cell homing for functional tissue regeneration in vivo are unstable and undergo rapid proteolysis in vivo, resulting in a short bioactive lifetime. Biomaterial scaffolds can be used as drug depots to encapsulate and release cell-stimulating and cell-homing factors to maintain the required therapeutic level at the defect site and to enable sustained, long-term and localized drug delivery 221 ( Fig. 7) . Various signalling cytokines, transcription factors and regulatory chemo kines, such as substance P 222 , BMP2 (ReFs 163, 223, 224 ), TGFβ3 (ReF.
149
) and VEGF 225 , have been loaded into scaffolds to enable localized release. Their release kinetics can be modulated by tailoring the physicochemical characteristics of the scaffold, such as the crosslinking density, swelling, molecule-scaffold affinity and scaffold degradability. For example, a gelatine hydrogel crosslinked with PEG diacrylate (PEGDA) can be loaded with HGF to recruit human bone marrow MSCs for endogenous regeneration. In this scaffold, heparin is conjugated to the hydrogel network, protecting HGF from enzymatic degradation and enabling extended HGF release through heparin-HGF intermolecular interactions 226 . Biomolecules can also be covalently linked to the scaffold for extended release. For example, SDF1α can be conjugated to a fibrinogen hydrogel to create a patch for the recruitment of stem cells antigen 1 (Sca1) + /C-kit + cells for endogenous heart repair 227 . The bound SDF1α is released at a constant rate from the patch for up to 10 days, in coordination with gel degradation and stem cell homing. The encapsulation and coordinated release of protein combinations further improve the efficacy of endogenous regeneration. For example, nerve growth factor (NGF) and BMP7 can be mixed with collagen and injected into pulp chambers and root canals of endodontically treated human teeth. This combination of growth factors results in the recruitment and differentiation of dental pulp stem cells and endothelial progenitor cells for dental pulp-like tissue regeneration 181 . PCL scaffolds can also be used for the simultaneous delivery of two growth factors. For example, SDF1α and BMP7 can be delivered in a PCL scaffold to trigger endogenous bone marrow MSC recruitment and local angiogenesis, enabling ectopic tooth regeneration 228 .
Designing a scaffold as a drug depot with optimal release kinetics requires the balancing of material properties and drug activity. For example, soft hydrogel scaffolds may provide ideal mechanical properties, but burst release of a payload is often inevitable. In addition, the physicochemical properties of biomolecules, such as stability, hydrophobicity and charge, are often not compatible with those of biomaterials. Microparticles and nanoparticles offer alternatives for encapsulation and subsequent incorporation of biomolecules into scaffolds 229 . Such hybrid approaches allow for the decoup ling of biomolecule encapsulation and release from material properties. For example, amelogenin, CTGF and BMP2 can be encapsulated into PLGA microspheres, which can then be 3D printed into different regions of a PCL-HA scaffold. Coordinated release of these proteins can be used to differentiate dental stem and progenitor cells into different tissues for regeneration of the periodontium complex 211 . Similarly, CTGF and TGFβ3 can be loaded into PLGA microspheres, followed by 3D printing into a PCL scaffold mimicking a human cadaver meniscus for knee meniscus regeneration. Release of the protein combination leads to the recruitment and differentiation of MSCs into fibrochondrocytelike cells, which synthesize zone-specific type I and II collagens, and this has been shown to lead to the restoration of the inhomogeneous mechanical properties of a sheep meniscus 151 . A hybrid system also enables biomolecule release in response to external cues, such as heat, light or magnetic fields, and the capability to control the release kinetics of drug combinations makes hybrid approaches interesting systems for the precise temporal control of stem cell signalling pathways 230 .
Surface modification. Signalling molecules anchored onto scaffolds improve cell attachment and proliferation following homing. A wide range of biomolecules, including fibronectin, vitronectin, laminin-5 and the Arg-Gly-Asp (RGD) peptide, have been immobilized onto scaffolds to increase cell attachment [231] [232] [233] . , nanofibres 294 and macroporous scaffolds 295 . Injectable scaffolds include hydrogels or fibres made from injectable precursors 296 , colloidal gels made from a mixture of polyelectrolyte and microparticles or nanoparticles 297 and colloidal gels made from a mixture of oppositely charged microparticles or nanoparticles 298 . Panel a is adapted with permission from ReFs [293] [294] [295] , Elsevier, RSC and Proceedings of the National Academy of Sciences, respectively. Panel b is adapted from ReFs 296, 297 , Macmillan Publishers Limited, and with permission from ReF. Adhesion molecule-mediated cell-scaffold interactions also play a key role in guiding stem cell differentiation. For example, adhesion of MSCs to PLGA, but not to PCL, promotes osteogenesis 234, 235 owing to differences in adhesion molecules; MSCs adhere to PCL primarily through vitronectin and to PLGA through collagen type I (ReF.
236
).
Therefore, effective conjugation methods applicable for incorporating various signalling molecules regardless of their molecular structure are essential for ideal scaffold modification. Polydopamine reacts with amine and thiol groups 237 and thus can be used to coat scaffold surfaces for uniform functionalization with biomolecules. This two-step method can be simplified by replacing the polydopamine coating process with a dopamine-based in situ polymerization processes, allowing molecules to co-dissolve with dopamine and be immobilized onto various material surfaces in a single step. Furthermore, molecules with a wide range of molecular masses (10 2 -10 6 Da) and functional groups, such as carboxyl, amine, thiol, quaternary ammonium and catechol groups 238 , can be immobilized by this approach.
Alternative functionalization strategies. Surface modification of biomaterials often relies on chemical conjugation and physical absorption, which involves the potential risk of protein denaturation. Alternatively, synthetic lipid bilayers can be applied onto nanofibre scaffolds 239 to shield the fibres from the external environment and to provide a biomolecule-friendly medium to promote cell receptor interactions and to preserve molecule integrity and function. Although such bottom-up functionalization approaches can be used to present individual receptors or receptor combinations to cells that are seeded in a scaffold, they are generally inadequate to replicate the complex properties and functions of the cell surface crucial for cell-cell interactions and cell proliferation. Therefore, top-down approaches have been explored, for example, for contact-dependent pancreatic β-cells. Thereby, tissue-specific ECMs are mixed with polylysine-modified microbeads, and through charge interactions, ECM components that contain essential signalling factors can be adsorbed onto the bead surface 240 . By mimicking native cell-cell contacts, the resulting microbead scaffold improves cell survival and function in vitro. Naturally derived cell membranes can also be used as coatings for synthetic materials to implement cell functions that are otherwise difficult to engineer 241 . Using such a cell membrane coating technique, various biomimetic nanoparticles have been made for therapeutic applications 242, 243 . Cell membranes derived from pancreatic β-cells can also be coated onto nanofibres to recreate the antigenic surface of the cells to improve cell proliferation and function 244 .
Physical material properties. The mechanical properties of biomaterial scaffolds, such as stiffness and elasticity, also play key roles in directing stem cell differentiation [245] [246] [247] . For example, elasticity strongly affects the fate of naive MSCs; soft matrices with a stiffness of 0.1-1 kPa, similar to the stiffness of the brain, are neurogenic; stiffer matrices with a stiffness of 8-17 kPa, similar to the stiffness of muscles, are myogenic; and rigid matrices with a stiffness ≥25 kPa, comparable to the stiffness of bone, are osteogenic 139 . Ideally, materials are designed with decoupled biochemical, mechanical and topographical properties [248] [249] [250] . Additionally, other physical features such as nanofibre alignment 251 , surface patterning of microparticles 252 and void spaces within hydrogels 253 impact the regenerative efficacy of biomaterial-based scaffolds.
Interspecies chimaeras
Interspecies chimaeras are invaluable tools to investigate stem cells and the regeneration of organs. Rat-mouse chimaeras were first developed in the 1970s, followed by a variety of other interspecies chimaeras, including goat-sheep chimaeras [254] [255] [256] . Pluripotent stem cells transplanted into blastocysts or embryos can generate interspecies chimaeras. For example, human-mouse embryos have been grown using human pluripotent stem cells 257 , however, with a low level of chimaerism 258 . It is hypothesized that the generation of human interspecies chimaeras may be better when using a similar species owing to similarities in early post-implantation development, embryo size, gestational length and developmental speed, which considerably affect efficiency. By creating a developmental niche, induced pluripotent stem cells can be used to regenerate whole organs in chimaeras; for example, a rat pancreas can be recreated using rat iPSCs in a mouse pancreas niche 259 . Such chimaera-generated organs could potentially be harvested and transplanted into human patients with organ failure. Data from the Organ Procurement and Transplantation Network indicate that 22 people on transplant lists die every day. Therefore, the ability to generate human organs in a chimaera model could improve access to organs for transplantation. The first human-pig chimaera was created using naive human pluripotent stem cells, which were engrafted in pig pre-implantation blastocysts, but showed limited contribution to post-implantation pig embryos; however, a higher level of chimaerism could be achieved using prime-state human pluripotent stem cells 260 . BMP2, bone morphogenic protein 2; FGF2, fibroblast growth factor 2; GDF5, growth/differentiation factor 5; HA , hyaluronic acid; HAp, hydroxyapatite; HGF, hepatocyte growth factor ; IGF1, insulin-like growth factor 1; OP1, osteogenic protein 1; PCL , poly-ε-caprolactone; PEG, polyethylene glycol; PGA , poly(glycolic acid); PLGA , poly(lactic-co-glycolic acid); SDF1α, stromal cell-derived factor 1α; TGFβ3, transforming growth factor β3; VEGF, vascular endothelial growth factor.
Controversy remains over human-non-human chimaeras, and the National Institutes of Health (NIH) released a moratorium in 2015 discontinuing funding for chimaera research in which human pluripotent cells are introduced into non-human vertebrate pre-gastrulation stage embryos 261 . The main concern is the potential humanization and development of human cognition in non-human hosts 262 . However, the NIH has proposed an amendment of the guidelines for chimaera research and is expected to reverse the moratorium 263 . The proposed guidelines prohibit the development of a human-like central nervous system (CNS), and thus human stem cells can be implanted only after the CNS has developed in non-human embryos. Furthermore, ethics committees have to be included in the grant approval process for chimaera research.
Conclusions and outlook
The ability of certain organisms to self-regenerate tissues and organs provides valuable insight into the microenvironments and cell populations required for regeneration. Biochemical modulation using growth factors is an effective technique to influence stem cell differentiation. However, biophysical cues, such as ultrasound, mechanical properties of the tissue and magnetic fields, also impact cell differentiation and maturation.
The presentation of precise biochemical and biophysical cues offers the possibility to manipulate and control stem cells and thus tissue regeneration in vitro and in situ.
In situ endogenous stem cell therapy uses the body's natural regenerative capabilities and avoids ex vivo manipulation of autologous cells 264, 265 . Similar to ESCs, which can self-organize into organoids and develop into 3D endoderm-derived and ectoderm-derived tissues, adult endogenous stem cells can also form organoids when grown in three dimensions and can be propagated in vitro for long periods of time 266 , allowing for the investigation of tissue regeneration, organogenesis and stem cell behaviour ex vivo. Different combinations of biomaterials and bioactive factors have been explored for the in situ regeneration of various tissues tested in preclinical animal models, for example, teeth and periodontium 267 , bone and cartilage 268 , muscle 269 , heart 270 , nerves 271 , kidneys 272 , skin 273 and liver 274 ( TaBle 2) . The first clinical studies using biomaterials in combination with specific growth factors to promote tissue regeneration have shown promising results. Scaffolds incorporating BMP7 (also called osteogenic protein 1), BMP2 or platelet-derived growth factor (PDGF) are already being used in clinical trials for bone regeneration 162 . For example, recombinant human PDGF loaded into a β-tricalcium phosphate scaffold (Augment Bone Graft, BioMimetic Therapeutics) is in clinical use to treat foot, ankle and distal radius fractures in Canada, Australia and New Zealand and is currently under review by the US Food and Drug Administration (FDA) 275 . Advances in biomaterial engineering and stem cell biology have enabled a new generation of instructive biomaterials that carry complex information, improve the in vivo stability of homing factors and coordinate spatiotemporal interactions with host cells 276 . To address the complexities of stem cell fate and activity 277 , material designs need to resemble the appropriate niche properties and the individual and synergistic signalling pathways of its components 278, 279 , especially considering cell-cell and cell-matrix interactions. Applying specific crosslinking methods, scaffolds can be made from both synthetic and natural polymers to incorporate tissue-specific niche properties 278, 279 . In void-forming hydrogels, pore formation depends on the rate of porogen elimination 253 , allowing for the decoupling of hydrogel bulk hydrolysis from cell release, endogenous cell infiltration and tissue formation. Such biomaterial platforms enable the analysis of niche cues and their interplay, guiding cell fate and tissue formation.
The native ECM is constantly remodelled. Dynamic materials allow scaffolds to remodel in response to cell development and environmental changes to better mimic cell-ECM interactions that control cell fate. Materials that degrade in response to cell attachment, migration and morphogenesis improve the efficacy of scaffolds in modulating cell fate and promoting tissue regeneration 277, 280 . Such responsive materials can provide both spatial and temporal control to modulate cell survival and phenotype 253 . The optimization of biomaterials will enable the regeneration of human tissues affected by congenital abnormalities, traumas and neoplasms. Interspecies chimaeras can provide models to investigate tissue regeneration and disease states. The ability to use iPSCs in human-mammalian chimaeras may enable organ generation for patients in need of an organ transplant. Genome editing techniques, including CRISPR technology, can be applied to optimize tissue growth and function. However, ethical considerations remain in stem cell regeneration research, and a multidisciplinary review by medical ethicists, scientists and veterinarians is required for chimaera research.
The complete regeneration of diseased tissues, organs and limbs is the ultimate goal of regenerative medicine. However, a number of challenges remain, and optimization of stem cell growth environments, the use of chimaeras and the development of smart biomaterial scaffolds will be key to achieving this goal.
